Tech Company Financing Transactions
Treadwell Therapeutics Funding Round
On 1/14/2020, Treadwell Therapeutics raised $27 million in Seed funding from TIO Bioventures.
Transaction Overview
Company Name
Announced On
1/14/2020
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Seed
Investors
TIO Bioventures (Tak Mak)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
411 Lafayette St. 6th Floor
New York, NY 10003
USA
New York, NY 10003
USA
Phone
Undisclosed
Website
Email Address
Overview
Treadwell Therapeutics is a clinical-stage oncology company exploiting cancer cells' vulnerabilities to develop first-in-class and best-in-class small molecules to address unmet needs in patients with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shane Burgess
Chief Financial Officer
Jeffrey Rona
Chief Medical Officer
Rachel Humphrey
Chief Scientific Officer
Mark Bray
Co-Founder
Tak Mak
VP - Bus. Development
Ryan Dietz
Browse more venture capital transactions:
Prev: 1/14/2020: Codagenix venture capital transaction
Next: 1/14/2020: Zipari venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs